Long-lasting remission in an adolescent with refractory hodgkin lymphoma after brentuximab vedotin-containing treatment. a case report

Category Primary study
JournalHaematologica
Year 2016
This article has no abstract
Epistemonikos ID: ef5d45668494088e9b61d527d1c21e49cb9558cf
First added on: Feb 08, 2025